Annual gross profit:
$16.10B+$26.87M(+0.17%)Summary
- As of today (September 17, 2025), TAK annual gross profit is $16.10 billion, with the most recent change of +$26.87 million (+0.17%) on March 1, 2025.
- During the last 3 years, TAK annual gross profit has fallen by -$2.08 billion (-11.44%).
- TAK annual gross profit is now -11.44% below its all-time high of $18.19 billion, reached on March 31, 2022.
Performance
TAK Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$4.09B+$527.28M(+14.82%)Summary
- As of today (September 17, 2025), TAK quarterly gross profit is $4.09 billion, with the most recent change of +$527.28 million (+14.82%) on June 1, 2025.
- Over the past year, TAK quarterly gross profit has dropped by -$138.04 million (-3.27%).
- TAK quarterly gross profit is now -26.18% below its all-time high of $5.53 billion, reached on June 30, 2021.
Performance
TAK quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$15.82B-$138.04M(-0.87%)Summary
- As of today (September 17, 2025), TAK TTM gross profit is $15.82 billion, with the most recent change of -$138.04 million (-0.87%) on June 1, 2025.
- Over the past year, TAK TTM gross profit has increased by +$771.79 million (+5.13%).
- TAK TTM gross profit is now -13.09% below its all-time high of $18.20 billion, reached on September 30, 2021.
Performance
TAK TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
TAK Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.2% | -3.3% | +5.1% |
| 3 y3 years | -11.4% | -3.3% | -3.8% |
| 5 y5 years | -2.1% | -4.4% | -6.3% |
TAK Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.4% | +0.2% | -7.6% | +28.6% | -5.4% | +5.1% |
| 5 y | 5-year | -11.4% | +0.2% | -26.2% | +28.6% | -13.1% | +5.1% |
| alltime | all time | -11.4% | +686.2% | -26.2% | +127.8% | -13.1% | +675.7% |
TAK Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $4.09B(+14.8%) | $15.82B(-0.9%) |
| Mar 2025 | $16.10B(+0.2%) | $3.56B(-8.5%) | $15.95B(-0.3%) |
| Dec 2024 | - | $3.89B(-9.3%) | $16.00B(-1.0%) |
| Sep 2024 | - | $4.28B(+1.4%) | $16.15B(+7.4%) |
| Jun 2024 | - | $4.22B(+17.3%) | $15.04B(-1.3%) |
| Mar 2024 | $16.08B(-5.2%) | $3.60B(-10.9%) | $15.24B(-1.8%) |
| Dec 2023 | - | $4.04B(+27.3%) | $15.52B(-2.4%) |
| Sep 2023 | - | $3.18B(-28.1%) | $15.89B(-5.0%) |
| Jun 2023 | - | $4.42B(+14.1%) | $16.73B(+1.2%) |
| Mar 2023 | $16.96B(-6.7%) | $3.88B(-12.3%) | $16.53B(+1.9%) |
| Dec 2022 | - | $4.42B(+10.3%) | $16.22B(+0.0%) |
| Sep 2022 | - | $4.01B(-5.1%) | $16.22B(-1.4%) |
| Jun 2022 | - | $4.22B(+18.2%) | $16.44B(-7.4%) |
| Mar 2022 | $18.19B(+7.3%) | $3.57B(-19.0%) | $17.76B(-1.2%) |
| Dec 2021 | - | $4.41B(+4.2%) | $17.98B(-1.2%) |
| Sep 2021 | - | $4.24B(-23.5%) | $18.20B(+0.7%) |
| Jun 2021 | - | $5.53B(+45.9%) | $18.06B(+7.5%) |
| Mar 2021 | $16.96B(+3.0%) | $3.79B(-18.1%) | $16.80B(-2.1%) |
| Dec 2020 | - | $4.63B(+12.9%) | $17.16B(+1.5%) |
| Sep 2020 | - | $4.10B(-4.0%) | $16.90B(+0.2%) |
| Jun 2020 | - | $4.27B(+3.0%) | $16.87B(+1.9%) |
| Mar 2020 | $16.46B(+43.1%) | $4.15B(-5.2%) | $16.56B(+7.1%) |
| Dec 2019 | - | $4.38B(+7.4%) | $15.47B(+10.4%) |
| Sep 2019 | - | $4.07B(+2.8%) | $14.01B(+11.3%) |
| Jun 2019 | - | $3.96B(+29.9%) | $12.59B(+10.2%) |
| Mar 2019 | $11.50B(+11.0%) | $3.05B(+4.3%) | $11.43B(+5.6%) |
| Dec 2018 | - | $2.92B(+10.2%) | $10.82B(+1.6%) |
| Sep 2018 | - | $2.65B(-5.1%) | $10.65B(+0.6%) |
| Jun 2018 | - | $2.80B(+14.1%) | $10.58B(+1.4%) |
| Mar 2018 | $10.37B(+10.3%) | $2.45B(-11.0%) | $10.44B(+2.3%) |
| Dec 2017 | - | $2.75B(+6.4%) | $10.20B(+1.0%) |
| Sep 2017 | - | $2.59B(-2.6%) | $10.11B(+3.7%) |
| Jun 2017 | - | $2.65B(+19.9%) | $9.75B(+1.6%) |
| Mar 2017 | $9.40B(-2.9%) | $2.21B(-16.6%) | $9.60B(+0.5%) |
| Dec 2016 | - | $2.65B(+19.0%) | $9.55B(+0.7%) |
| Sep 2016 | - | $2.23B(-10.9%) | $9.48B(-1.7%) |
| Jun 2016 | - | $2.50B(+15.7%) | $9.64B(+1.0%) |
| Mar 2016 | $9.68B(-6.3%) | $2.16B(-16.4%) | $9.54B(+0.4%) |
| Dec 2015 | - | $2.59B(+8.3%) | $9.50B(+0.9%) |
| Sep 2015 | - | $2.39B(-0.6%) | $9.42B(-3.0%) |
| Jun 2015 | - | $2.40B(+13.0%) | $9.71B(-1.7%) |
| Mar 2015 | $10.33B(-2.5%) | $2.13B(-14.9%) | $9.88B(-5.3%) |
| Dec 2014 | - | $2.50B(-6.8%) | $10.43B(-7.1%) |
| Sep 2014 | - | $2.68B(+4.4%) | $11.22B(-3.2%) |
| Jun 2014 | - | $2.57B(-4.1%) | $11.59B(-3.5%) |
| Mar 2014 | $10.59B(-4.5%) | $2.68B(-18.6%) | $12.01B(-0.9%) |
| Dec 2013 | - | $3.29B(+7.9%) | $12.12B(-1.5%) |
| Sep 2013 | - | $3.05B(+2.1%) | $12.30B(-3.6%) |
| Jun 2013 | - | $2.99B(+7.2%) | $12.76B(-5.2%) |
| Mar 2013 | $11.09B | $2.79B(-19.7%) | $13.45B(-2.9%) |
| Dec 2012 | - | $3.47B(-1.1%) | $13.86B(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $3.51B(-4.8%) | $14.00B(+0.7%) |
| Jun 2012 | - | $3.69B(+15.5%) | $13.90B(+2.0%) |
| Mar 2012 | $12.55B(-2.5%) | $3.19B(-11.8%) | $13.63B(+0.6%) |
| Dec 2011 | - | $3.62B(+6.2%) | $13.54B(+1.2%) |
| Sep 2011 | - | $3.41B(-0.2%) | $13.38B(+0.6%) |
| Jun 2011 | - | $3.41B(+10.0%) | $13.31B(+2.5%) |
| Mar 2011 | $12.87B(+1.2%) | $3.10B(-10.3%) | $12.98B(+1.2%) |
| Dec 2010 | - | $3.46B(+4.0%) | $12.83B(+1.1%) |
| Sep 2010 | - | $3.33B(+7.8%) | $12.69B(+0.3%) |
| Jun 2010 | - | $3.09B(+4.7%) | $12.65B(-0.6%) |
| Mar 2010 | $12.72B(+2.4%) | $2.95B(-11.1%) | $12.72B(+3.5%) |
| Dec 2009 | - | $3.32B(+1.1%) | $12.29B(+2.1%) |
| Sep 2009 | - | $3.29B(+4.0%) | $12.03B(+3.9%) |
| Jun 2009 | - | $3.16B(+25.3%) | $11.58B(+3.2%) |
| Mar 2009 | $12.42B(+29.5%) | $2.52B(-17.6%) | $11.22B(+2.7%) |
| Dec 2008 | - | $3.06B(+8.0%) | $10.92B(+4.5%) |
| Sep 2008 | - | $2.83B(+1.2%) | $10.45B(+5.1%) |
| Jun 2008 | - | $2.80B(+26.0%) | $9.94B(+4.0%) |
| Mar 2008 | $9.59B(+9.3%) | - | - |
| Mar 2008 | - | $2.22B(-14.3%) | $9.56B(+2.5%) |
| Dec 2007 | - | $2.59B(+11.7%) | $9.33B(+1.9%) |
| Sep 2007 | - | $2.32B(-4.1%) | $9.15B(+3.0%) |
| Jun 2007 | - | $2.42B(+21.8%) | $8.88B(+1.0%) |
| Mar 2007 | $8.77B(+6.7%) | - | - |
| Mar 2007 | - | $1.99B(-17.8%) | $8.79B(+1.9%) |
| Dec 2006 | - | $2.42B(+17.6%) | $8.63B(+2.7%) |
| Sep 2006 | - | $2.06B(-11.8%) | $8.40B(+1.7%) |
| Jun 2006 | - | $2.33B(+27.6%) | $8.26B(+0.9%) |
| Mar 2006 | $8.22B(+4.7%) | - | - |
| Mar 2006 | - | $1.83B(-16.5%) | $8.19B(+0.4%) |
| Dec 2005 | - | $2.19B(+14.1%) | $8.16B(-0.5%) |
| Sep 2005 | - | $1.92B(-15.1%) | $8.19B(+1.2%) |
| Jun 2005 | - | $2.26B(+25.9%) | $8.10B(+2.8%) |
| Mar 2005 | $7.85B(+8.6%) | - | - |
| Mar 2005 | - | $1.79B(-19.5%) | $7.88B(+29.5%) |
| Dec 2004 | - | $2.23B(+22.1%) | $6.09B(+57.7%) |
| Sep 2004 | - | $1.82B(-10.6%) | $3.86B(+89.4%) |
| Jun 2004 | - | $2.04B | $2.04B |
| Mar 2004 | $7.23B(+18.2%) | - | - |
| Mar 2003 | $6.12B(+14.6%) | - | - |
| Mar 2002 | $5.34B(+9.4%) | - | - |
| Mar 2001 | $4.88B(+10.7%) | - | - |
| Mar 2000 | $4.41B(+37.0%) | - | - |
| Mar 1999 | $3.22B(+0.2%) | - | - |
| Mar 1998 | $3.21B(-7.0%) | - | - |
| Mar 1997 | $3.45B(-9.6%) | - | - |
| Mar 1996 | $3.82B(+9.3%) | - | - |
| Mar 1995 | $3.49B(+14.3%) | - | - |
| Mar 1994 | $3.06B(+19.1%) | - | - |
| Mar 1993 | $2.57B(+12.4%) | - | - |
| Mar 1992 | $2.28B(+11.4%) | - | - |
| Mar 1991 | $2.05B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual gross profit?
- What is the all time high annual gross profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual gross profit year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly gross profit?
- What is the all time high quarterly gross profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly gross profit year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM gross profit?
- What is the all time high TTM gross profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM gross profit year-on-year change?
What is Takeda Pharmaceutical Company Limited annual gross profit?
The current annual gross profit of TAK is $16.10B
What is the all time high annual gross profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual gross profit is $18.19B
What is Takeda Pharmaceutical Company Limited annual gross profit year-on-year change?
Over the past year, TAK annual gross profit has changed by +$26.87M (+0.17%)
What is Takeda Pharmaceutical Company Limited quarterly gross profit?
The current quarterly gross profit of TAK is $4.09B
What is the all time high quarterly gross profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly gross profit is $5.53B
What is Takeda Pharmaceutical Company Limited quarterly gross profit year-on-year change?
Over the past year, TAK quarterly gross profit has changed by -$138.04M (-3.27%)
What is Takeda Pharmaceutical Company Limited TTM gross profit?
The current TTM gross profit of TAK is $15.82B
What is the all time high TTM gross profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM gross profit is $18.20B
What is Takeda Pharmaceutical Company Limited TTM gross profit year-on-year change?
Over the past year, TAK TTM gross profit has changed by +$771.79M (+5.13%)